First glimpses of the neurobiology of autism spectrum disorder.

Rapid progress in identifying the genes underlying autism spectrum disorder (ASD) has provided the substrate for a first wave of analyses into the underlying neurobiology. This review describes the consensus across these diverse analyses, highlighting two distinct sets of genes: 1) Genes that regulate chromatin and transcription, especially in cortical projection neurons and striatal medium spiny neurons during mid-fetal development; and 2) Genes involved in synapse development and function, especially during infancy and early childhood, and differentially expressed in the post mortem ASD brain. Both gene sets are also regulatory targets of the ASD genes CHD8 and FMRP. It remains to be seen whether these represent two independent paths to the ASD phenotype or two components of a common path.

[1]  Jay Shendure,et al.  Disruptive CHD8 Mutations Define a Subtype of Autism Early in Development , 2014, Cell.

[2]  J. Danesh,et al.  Large-scale association analysis identifies new risk loci for coronary artery disease , 2013 .

[3]  Christopher S. Poultney,et al.  Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci , 2015, Neuron.

[4]  Christopher S. Poultney,et al.  Synaptic, transcriptional, and chromatin genes disrupted in autism , 2014, Nature.

[5]  T. Bourgeron,et al.  Neurobiology of autism gene products: towards pathogenesis and drug targets , 2014, Psychopharmacology.

[6]  Stephen J. Guter,et al.  Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum Disorders , 2014, American journal of human genetics.

[7]  Kathryn Roeder,et al.  Integrated Model of De Novo and Inherited Genetic Variants Yields Greater Power to Identify Risk Genes , 2013, PLoS genetics.

[8]  Stephan J Sanders,et al.  The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment , 2015, Nature Communications.

[9]  E. Vichinsky.  Alpha thalassemia major--new mutations, intrauterine management, and outcomes. , 2009, Hematology. American Society of Hematology. Education Program.

[10]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[11]  Michael F. Walker,et al.  De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.

[12]  Kathryn Roeder,et al.  Most genetic risk for autism resides with common variation , 2014, Nature Genetics.

[13]  Evan T. Geller,et al.  Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.

[14]  Dennis Vitkup,et al.  Diverse types of genetic variation converge on functional gene networks involved in schizophrenia , 2012, Nature Neuroscience.

[15]  D. Vitkup,et al.  Network properties of genes harboring inherited disease mutations , 2008, Proceedings of the National Academy of Sciences.

[16]  B. V. van Bon,et al.  Fourteen new cases contribute to the characterization of the 7q11.23 microduplication syndrome. , 2009, European journal of medical genetics.

[17]  Patrick E. Rothwell,et al.  Autism-Associated Neuroligin-3 Mutations Commonly Impair Striatal Circuits to Boost Repetitive Behaviors , 2014, Cell.

[18]  J. Stockman.  Association between Microdeletion and Microduplication at 16p11.2 and Autism , 2009 .

[19]  Allan R. Jones,et al.  Transcriptional Landscape of the Prenatal Human Brain , 2014, Nature.

[20]  C. Betancur,et al.  Etiological heterogeneity in autism spectrum disorders: More than 100 genetic and genomic disorders and still counting , 2011, Brain Research.

[21]  Allan R. Jones,et al.  Transcriptional Architecture of the Primate Neocortex , 2012, Neuron.

[22]  K. Gunderson,et al.  Speech delay and autism spectrum behaviors are frequently associated with duplication of the 7q11.23 Williams-Beuren syndrome region , 2007, Genetics in Medicine.

[23]  Stephan J. Sanders,et al.  Genotype to phenotype relationships in autism spectrum disorders , 2014, Nature Neuroscience.

[24]  Ilse Gantois,et al.  Chronic administration of AFQ056/Mavoglurant restores social behaviour in Fmr1 knockout mice , 2013, Behavioural Brain Research.

[25]  Matthew W State,et al.  Autism spectrum disorders: from genes to neurobiology , 2015, Current Opinion in Neurobiology.

[26]  Manolis Kellis,et al.  CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors , 2014, Proceedings of the National Academy of Sciences.

[27]  L. Maquat,et al.  A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. , 1998, Trends in biochemical sciences.

[28]  Uwe Ohler,et al.  FMR1 targets distinct mRNA sequence elements to regulate protein expression , 2012, Nature.

[29]  Sharmila Banerjee-Basu,et al.  AutDB: a gene reference resource for autism research , 2008, Nucleic Acids Res..

[30]  Michael Wigler,et al.  Rare De Novo Variants Associated with Autism Implicate a Large Functional Network of Genes Involved in Formation and Function of Synapses , 2011, Neuron.

[31]  David R. O'Brien,et al.  Cell Type-Specific Expression Analysis to Identify Putative Cellular Mechanisms for Neurogenetic Disorders , 2014, The Journal of Neuroscience.

[32]  Garry R. Cutting,et al.  Cystic fibrosis genetics: from molecular understanding to clinical application , 2014, Nature Reviews Genetics.

[33]  David W. Evans,et al.  Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence , 2013, The Lancet Neurology.

[34]  Matthew W. State,et al.  The Emerging Biology of Autism Spectrum Disorders , 2012, Science.

[35]  Boris Yamrom,et al.  Rare De Novo and Transmitted Copy-Number Variation in Autistic Spectrum Disorders , 2011, Neuron.

[36]  E. Ben-David,et al.  Combined analysis of exome sequencing points toward a major role for transcription regulation during brain development in autism , 2013, Molecular Psychiatry.

[37]  Aaron Isaacs,et al.  Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant , 2012, Psychopharmacology.

[38]  Anne-Marie Le Sourd,et al.  Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2 , 2012, Nature.

[39]  D. Pinto,et al.  Structural variation of chromosomes in autism spectrum disorder. , 2008, American journal of human genetics.

[40]  Kenny Q. Ye,et al.  Strong Association of De Novo Copy Number Mutations with Autism , 2007, Science.

[41]  Wei Niu,et al.  Coexpression Networks Implicate Human Midfetal Deep Cortical Projection Neurons in the Pathogenesis of Autism , 2013, Cell.

[42]  Bradley P. Coe,et al.  Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.

[43]  Shannon E. Ellis,et al.  Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism , 2014, Nature Communications.

[44]  D. Licatalosi,et al.  FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism , 2011, Cell.

[45]  Robert T. Schultz,et al.  Common genetic variants on 5p14.1 associate with autism spectrum disorders , 2009, Nature.

[46]  Bradley P. Coe,et al.  Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders , 2012, Science.

[47]  Kenny Q. Ye,et al.  De Novo Gene Disruptions in Children on the Autistic Spectrum , 2012, Neuron.

[48]  Kathryn Roeder,et al.  De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder. , 2014, Cell reports.

[49]  J. Kleinman,et al.  Spatiotemporal transcriptome of the human brain , 2011, Nature.

[50]  M. Leboyer,et al.  Autism, language delay and mental retardation in a patient with 7q11 duplication , 2007, Journal of Medical Genetics.

[51]  Michael Snyder,et al.  Integrated systems analysis reveals a molecular network underlying autism spectrum disorders , 2014, Molecular systems biology.

[52]  S. Horvath,et al.  Transcriptomic Analysis of Autistic Brain Reveals Convergent Molecular Pathology , 2011, Nature.

[53]  C. Hultman,et al.  The familial risk of autism. , 2014, JAMA.

[54]  Erik T Parner,et al.  Recurrence of autism spectrum disorders in full- and half-siblings and trends over time: a population-based cohort study. , 2013, JAMA pediatrics.

[55]  M. Bear,et al.  Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice , 2012, Neuron.

[56]  S. Horvath,et al.  Integrative Functional Genomic Analyses Implicate Specific Molecular Pathways and Circuits in Autism , 2013, Cell.

[57]  Kathryn Roeder,et al.  DAWN: a framework to identify autism genes and subnetworks using gene expression and genetics , 2014, Molecular Autism.

[58]  Adam J. Schwarz,et al.  CNVs conferring risk of autism or schizophrenia affect cognition in controls , 2013, Nature.

[59]  Stephan J Sanders,et al.  Cross-Disorder Comparison of Four Neuropsychiatric CNV Loci , 2014, Current Genetic Medicine Reports.

[60]  Gary D Bader,et al.  Functional impact of global rare copy number variation in autism spectrum disorders , 2010, Nature.

[61]  Sharmila Banerjee-Basu,et al.  SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs) , 2013, Molecular Autism.

[62]  Kathryn Roeder,et al.  Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism , 2011, Neuron.

[63]  C. Arango,et al.  The neurobiology of autism spectrum disorders , 2014, European Psychiatry.

[64]  Aaron J. Bell,et al.  PDE-4 Inhibition Rescues Aberrant Synaptic Plasticity in Drosophila and Mouse Models of Fragile X Syndrome , 2015, The Journal of Neuroscience.

[65]  Aaron J. Bell,et al.  Pharmacological reversal of synaptic plasticity deficits in the mouse model of Fragile X syndrome by group II mGluR antagonist or lithium treatment , 2010, Brain Research.

[66]  P. Bolton,et al.  Heritability of Autism Spectrum Disorder in a UK Population-Based Twin Sample. , 2015, JAMA psychiatry.

[67]  R. McPherson.  Genome-Wide Association Studies of Cardiovascular Disease in European and Non-European Populations , 2014, Current Genetic Medicine Reports.

[68]  S. Horvath,et al.  A General Framework for Weighted Gene Co-Expression Network Analysis , 2005, Statistical applications in genetics and molecular biology.

[69]  Deborah A Nickerson,et al.  De novo rates and selection of large copy number variation. , 2010, Genome research.

[70]  J. Sebat,et al.  Spatiotemporal 16p11.2 Protein Network Implicates Cortical Late Mid-Fetal Brain Development and KCTD13-Cul3-RhoA Pathway in Psychiatric Diseases , 2015, Neuron.

[71]  D. Conrad,et al.  Recurrent 16p11.2 microdeletions in autism. , 2007, Human molecular genetics.

[72]  Boris Yamrom,et al.  The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.